United Therapeutics (UTHR) Share-based Compensation Growth (3y) (2012 - 2026)
United Therapeutics (UTHR) Share-based Compensation Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 10.06% |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 9.14% |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 0.43% |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | -8.13% |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | -1.73% |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | -8.04% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Alkermes | 8.14 Bn | 7.48 Bn | 397.90 Mn | 50.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 88.54% |
| Dec 31, 2025 | -44.38% |
| Sep 30, 2025 | 44.48% |
| Jun 30, 2025 | -81.62% |
| Mar 31, 2025 | 39.68% |
| Dec 31, 2024 | -707.23% |
| Sep 30, 2024 | 56.05% |
| Jun 30, 2024 | -84.91% |
| Mar 31, 2024 | -34.25% |
| Dec 31, 2023 | -27.91% |
| Sep 30, 2023 | 54.50% |
| Jun 30, 2023 | -35.65% |
| Mar 31, 2023 | -33.93% |
| Dec 31, 2022 | -30.40% |
| Sep 30, 2022 | -34.19% |
| Jun 30, 2022 | -36.69% |
| Mar 31, 2022 | -39.64% |
| Dec 31, 2021 | -58.51% |
| Sep 30, 2021 | -75.95% |
| Jun 30, 2021 | 18.02% |